Literature DB >> 833379

Platelet thrombopathy in asthmatic patients with elevated immunoglobulin e.

C A Maccia, J S Gallagher, G Ataman, H I Glueck, S M Brooks, I L Bernstein.   

Abstract

Abnormalities of second-wave platelet aggregation were demonstrated in 17 of 33 asthmatic patients in whom drug and diet intake were controlled in the hospital. Mean abnormal responses were significantly greater after epinephrine- (p less than 0.001), adenosine diphosphate-(less than 0.001), collagen- (p = 0.01), and thrombin- (p less than 0.001) induced platelet aggregation in patients with immunologically mediated asthma and serum IgE levels greater than 250 U/ml as compared to patients without immunologic factors and/or normal controls. Mean pollen-specific radioallergosorbent (RAST) binding was also significantly higher in patients with abnormal aggregation as compared to normal platelet responders (p = 0.02). Release of serotonin generally reflected abnormal aggregation patterns in asthmatic patients. Platelet factor 4 release was significantly decreased in the same groups of patients. These results suggest that the allergic state may affect platelet membrane responsiveness to multiple aggregating agents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833379     DOI: 10.1016/0091-6749(77)90210-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

Review 1.  Platelet activation during allergic inflammation.

Authors:  Alicja Kasperska-Zajac; Barbara Rogala
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

2.  Reduced capillary resistance in allergic patients.

Authors:  R Urbanek; A H Sutor; G Klein
Journal:  Eur J Pediatr       Date:  1978-08-17       Impact factor: 3.183

Review 3.  Novel uses for anti-platelet agents as anti-inflammatory drugs.

Authors:  S C Pitchford
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

4.  A Human Platelet Receptor Protein Microarray Identifies the High Affinity Immunoglobulin E Receptor Subunit α (FcεR1α) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) Ligand.

Authors:  Yi Sun; Christophe Vandenbriele; Alexandre Kauskot; Peter Verhamme; Marc F Hoylaerts; Gavin J Wright
Journal:  Mol Cell Proteomics       Date:  2015-02-23       Impact factor: 5.911

Review 5.  Platelet-Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma.

Authors:  Sajeel A Shah; Clive P Page; Simon C Pitchford
Journal:  Front Med (Lausanne)       Date:  2017-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.